Text Size
A A A
U. S. Department of Health and Human Services
Skip Navigation

Home > RePORTER > Project Information

Project InformationProject Information Help

Project Number: 5R01ES011740-10 Contact PI / Project Leader: WEI, QINGYI
Title: MOLECULAR EPIDEMIOLOGY OF DNA REPAIR IN HEAD AND NECK CANCER Awardee Organization: UT MD ANDERSON CANCER CTR
Description
Abstract Text:
Project Summary/Abstract Tobacco and alcohol use and genetic susceptibility are major risk factors for squamous cell carcinoma of the head and neck (SCCHN). Identification of susceptible individuals can effectively prevent this disease by avoiding tobacco and alcohol use. Tobacco carcinogens cause a variety of DNA damage in the target cells, which may lead to uncontrolled cell growth, but the cells evolve to have the mechanism of programmed cell death or apoptosis that helps eliminate cells with excessive damage to DNA and thus reduce risk of cancer. There are at least two known apoptotic pathways, intrinsic and extrinsic, that lead to cell death in response to excessive DNA damage. Many genes participate in these two apoptotic pathways, and there is an established flow cytometry method to detect the apoptosis phenotype. In this new grant application, we propose to perform the phenotypic apoptosis and genotyping assays in 600 newly recruited cases and 600 controls and to perform genotyping assays with stored DNA samples from previously recruited 1,000 SCCHN cases and 1,000 controls. For the genotyping, we propose to focus on the common, possibly functional single nucleotide polymorphisms (SNPs) that either cause amino acid changes or sequence variation in the regulatory regions that may alter gene expression or are reportedly associated with risk of smoking-related cancers. A total of 88 possibly functional SNPs in 45 apoptosis-related genes will be genotyped by the Taqman genotyping method using genomic DNA from 1,600 SCCHN cases (600 prospective and 1,000 retrospective) and 1,600 cancer- free controls (also 600 prospective and 1,000 retrospective). Our specific aims are: AIM 1: To determine the association between the apoptotic phenotype of lymphocytes and risk of SCCHN in 600 prospectively identified cases and 600 hospital-based controls frequency matched by age, sex, ethnicity/race and residence. We will test the hypothesis that lower levels of apoptotic capacity are associated with increased risk of SCCHN. AIM 2: To determine the functional relevance of selected common variants in apoptotic pathways in the 600 cases and 600 controls by identifying genotypes that predict the phenotype. We will test the hypothesis that possibly functional genetic variants of selected apoptotic genes have an effect on the apoptotic phenotype. AIM 3: To determine the association between common variant genotypes of the selected apoptosis-related genes and risk of SCCHN. We will test the hypothesis that adverse genotypes of selected apoptosis-related genes are associated with increased risk of SCCHN. This proposed association study is highly hypothesis-driven, expanding our preliminary data on the findings of a novel p53-PHB-PIG3 apoptosis mechanism. This study will identify genetic factors that predict the apoptotic phenotype and risk of SCCHN and thus will advance our knowledge in the etiology of SCCHN. The long-term goal of this study is to identify effective biomarkers for risk assessment and to identify at-risk individuals who can be targeted for primary prevention and early detection of SCCHN in the general population. Project Narrative This proposed study is to investigate the roles of genetic factors, as well as their interactions with tobacco and alcohol use, in the etiology of squamous cell carcinomas of the oral cavity, pharynx, and larynx (SCCHN), expanding our findings of a novel apoptosis mechanism that has not been described before. Therefore, this study will help understand the underlying mechanisms of the correlation between apoptosis genotypes and phenotypes to be measured and the roles they may play in the etiology of SCCHN. The long- term goal of this study is to identify effective biomarkers that can be used to identify at-risk individuals who will be targeted for primary prevention and early detection of SCCHN in the general population.
Project Terms:
abstracting; Age; Alcohol consumption; Alleles; Amino Acids; Apoptosis; Apoptotic; Applications Grants; base; Benzo(a)pyrene; Biological Assay; biomarker; cancer risk; Cell Death; Cell physiology; Cells; computer based statistical methods; Core Protein; Data; Data Collection; Databases; Dimensions; Disease; DNA; DNA Damage; DNA Repair; DNA Repair Gene; Early Diagnosis; Epidemiologic Studies; Epidemiology; Epoxy Compounds; ERCC1 gene; ERCC3 gene; Ethnic group; Ethnicity aspects; Etiology; Evaluation; Family history of; Flow Cytometry; Frequencies (time pattern); Future; gene environment interaction; Gene Expression; Gene Frequency; General Population; Genes; Genetic; Genetic Predisposition to Disease; Genetic Transcription; genetic variant; Genome Stability; Genomics; Genotype; Glycols; Goals; Haplotypes; Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma; Head and neck structure; high throughput screening; Hospitals; In Vitro; Individual; instrument; Knowledge; Laryngeal Squamous Cell Carcinoma; Larynx; Lead; Lymphocyte; Malignant Neoplasms; Measures; Messenger RNA; Methods; Minor; Modeling; Molecular Epidemiology; mouth squamous cell carcinoma; mRNA Expression; Multivariate Analysis; National Institute of Environmental Health Sciences; Nature; Newly Diagnosed; novel; Nucleic Acid Regulatory Sequences; Nucleotide Excision Repair; Oral cavity; Participant; Pathway interactions; Pharyngeal structure; Phase; Phenotype; Plasmids; Play; Predisposition; prevent; Primary Prevention; Principal Component Analysis; prospective; protein expression; Proteins; Race; Recruitment Activity; repository; Research Design; residence; Resources; response; Risk; Risk Assessment; Risk Factors; RNA; Role; Sample Size; Sampling; Selection Criteria; sex; Single Nucleotide Polymorphism; Site; Smoker; Smoking; Specimen; Statistical Models; Stratification; Subgroup; Testing; Time; Tobacco use; Tobacco-Associated Carcinogen; Transfection; tumor; uncontrolled cell growth; Validation; Variant; XPA gene



The RePORTER database is available to all public users at http://exporter.nih.gov/. As the data are available for bulk download, the RePORTER system reserves the right to block IP addresses that fail to adhere to instructions in the system’s robots.txt files or submit requests at a rate that negatively impacts service delivery to other users. RePORTER reserves the right to terminate any automated query to the RePORTER application that negatively affects service delivery to other users.

Page Last Updated on February 16, 2013
This site is best viewed with Internet Explorer (7.0 or higher) or Mozilla Firefox (3.0).

NIH...Turning Discovery Into Health®
RePORTERE3